The blue rubber bleb nevus syndrome (BRBNS, syn. bean syndrome) is a rare disease
characterized by multiple cutaneous and gastrointestinal venous malformations
associated with severe bleeding. However, the underlying molecular mechanisms
are unknown and no targeted therapeutic approach exists to date. Here we report
the case of a 19-year-old male patient with severe BRBNS in whom we analyzed the
expression of tyrosine kinases frequently involved in tumor development by
immunohistochemistry (vascular endothelial growth factor receptor-2, stem cell
growth factor receptor (c-kit), platelet-derived growth factor
receptor-β, and stem cell tyrosine kinase-1). A prominent expression of
c-kit was detectable in smaller blood vessels, which also showed a moderate
expression of the proliferation marker MIB1. Surprisingly, other growth factor
receptors stained negatively. We therefore conclude that pharmacological
inhibition of the c-kit signaling pathway in cavernous hemangiomas by selective
kinase inhibitors may offer options in the treatment of BRBNS patients.